Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Value of Novel Biomarker on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

NCT07418242 is registered in ClinicalTrials.gov with Guowei Tu as lead sponsor.

NCT NCT07418242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07418242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Value of Novel Biomarker on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients
Lead sponsor
Guowei Tu
Phase
Observational
Overall status
Completed
Start date
February 23, 2026
Completion date
August 31, 2026
Enrollment
319 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery associated - acute kidney injury, critical illness